SYNLOGIC, INC. Employee Benefits and Share-based Compensation
SYNLOGIC, INC. (SYBX) reported Employee Benefits and Share-based Compensation of $200.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-06.
Financial Statements › Notes › Compensation Related Costs
us-gaap:EmployeeBenefitsAndShareBasedCompensation · last filed 2025-03-06
- SYNLOGIC, INC. employee benefits and share-based compensation for fiscal 2024 was $200.00K, a 99999900.00% increase from fiscal 2023.
- SYNLOGIC, INC. employee benefits and share-based compensation for fiscal 2023 was $0.20.
| Period end | Employee Benefits and Share-based Compensation 12 month |
|---|---|
| 2024-12-31 | $200.00K 10-K · filed 2025-03-06 |
| 2023-12-31 | $0.20 10-K · filed 2024-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |